|
|
Volumn 3, Issue 3, 2011, Pages 221-222
|
|
The amazing, multipusrpose antibody
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFLIBERCEPT;
BELIMUMAB;
BENLYSTA;
BLINATUMOMAB;
BRENTUXIMAB VEDOTIN;
CATUMAXOMAB;
CYTOKINE ANTIBODY;
FC RECEPTOR;
IMMUNOGLOBULIN G;
INTERLEUKIN 12 ANTIBODY;
INTERLEUKIN 18 ANTIBODY;
INTERLEUKIN 1ALPHA ANTIBODY;
INTERLEUKIN 1BETA ANTIBODY;
IPILIMUMAB;
MONOCLONAL ANTIBODY;
RAXIBACUMAB;
UNCLASSIFIED DRUG;
YERVOY;
SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ANTIBODY LIBRARY;
ANTIGEN BINDING;
ASCITES;
BINDING AFFINITY;
DRUG APPROVAL;
DRUG MARKETING;
DRUG TARGETING;
EDITORIAL;
EUROPEAN UNION;
HUMAN;
MALIGNANT ASCITES;
MALIGNANT NEOPLASTIC DISEASE;
ANIMAL;
ANTIBODY AFFINITY;
ANTIBODY SPECIFICITY;
IMMUNOLOGY;
MEDICAL RESEARCH;
METHODOLOGY;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODY AFFINITY;
ANTIBODY SPECIFICITY;
BIOMEDICAL RESEARCH;
HUMANS;
SINGLE-CHAIN ANTIBODIES;
|
|
EID: 79955654100
PISSN: 19420862
EISSN: 19420870
Source Type: Journal
DOI: 10.4161/mabs.3.3.15625 Document Type: Editorial |
|
Times cited : (10)
|
|
References (0)
|
